SYN - Synthetic Biologics, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
6.85M
Enterprise Value 3
3.53M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
67.93
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
-0.23

Trading Information

Stock Price History

Beta (3Y Monthly) 1.98
52-Week Change 3-46.40%
S&P500 52-Week Change 318.11%
52 Week High 30.9100
52 Week Low 30.0000
50-Day Moving Average 30.4169
200-Day Moving Average 30.4855

Share Statistics

Avg Vol (3 month) 378.51k
Avg Vol (10 day) 377.4k
Shares Outstanding 516.81M
Float 16.68M
% Held by Insiders 10.10%
% Held by Institutions 120.67%
Shares Short (Oct 31, 2019) 4172.13k
Short Ratio (Oct 31, 2019) 42.95
Short % of Float (Oct 31, 2019) 41.03%
Short % of Shares Outstanding (Oct 31, 2019) 41.02%
Shares Short (prior month Sep 30, 2019) 4183.96k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 235/1
Last Split Date 3Aug 13, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-62.27%
Return on Equity (ttm)-146.08%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -15.46M
Net Income Avi to Common (ttm)-27.85M
Diluted EPS (ttm)-1.7830
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)18.65M
Total Cash Per Share (mrq)1.11
Total Debt (mrq)780k
Total Debt/Equity (mrq)5.35
Current Ratio (mrq)3.52
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-13.56M
Levered Free Cash Flow (ttm)-7.96M